Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)
Latest Information Update: 03 Jul 2023
At a glance
- Drugs Linvoseltamab (Primary)
- Indications Multiple myeloma
- Focus Expanded access; Therapeutic Use
- Sponsors Regeneron Pharmaceuticals
Most Recent Events
- 28 Dec 2021 New trial record